SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-23-001882
Filing Date
2023-08-10
Accepted
2023-08-10 16:34:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422fbrx_08102023.htm SC 13G 275793
2 JOINT FILING AGREEMENT ex991to13g07422fbrx_08102023.htm EX-99.1 8338
  Complete submission text file 0000921895-23-001882.txt   285814
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 231160141
SIC: 2834 Pharmaceutical Preparations